SCHEMBL25934672

SCHEMBL25934672

COCCOc1ccc(S(=O)(=O)C2(C(=O)OC)CC2)nc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.40
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
PKM P14618 1/20 0.38
CYP2C19 P33261 1/20 0.38
BACE1 P56817 2/20 0.37
MMP13 P45452 11/20 0.37
MMP1 P03956 8/20 0.37
MMP2 P08253 5/20 0.37
MMP3 P08254 5/20 0.37
MMP8 P22894 2/20 0.36
MMP9 P14780 6/20 0.35
ADAM17 P78536 5/20 0.35
MAPT P10636 1/20 0.35
SLC22A12 Q96S37 1/20 0.35
MMP7 P09237 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MMP10 P09238 1/20 0.33
CHEK2 O96017 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25317994 0.90 RAB9A (0.40) RAB9ACYP3A4CYP2C9PKMCYP2C19
SCHEMBL26023163 0.90 MMP13 (0.40) RAB9ACYP3A4CYP2C9PKMCYP2C19
SCHEMBL30507123 0.90 RAB9A (0.40) RAB9ACYP3A4CYP2C9PKMCYP2C19
SCHEMBL25313592 0.90 RAB9A (0.38) RAB9ACYP3A4CYP2C9PKMCYP2C19
SCHEMBL30506855 0.90 RAB9A (0.38) RAB9ACYP3A4CYP2C9PKMCYP2C19
SCHEMBL25314065 0.78 RAB9A (0.43) RAB9ACYP3A4CYP2C9PKMCYP2C19
SCHEMBL30507020 0.78 RAB9A (0.43) RAB9ACYP3A4CYP2C9PKMCYP2C19
SCHEMBL26036191 0.75 MMP9 (0.43) BACE1MMP13MMP1MMP9ADAM17
SCHEMBL25320520 0.72 CYP3A4 (0.53) CYP3A4CYP2C9PKMCYP2C19MMP13
SCHEMBL26027425 0.72 MMP13 (0.63) CYP3A4CYP2C9PKMCYP2C19MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed